Introducing Zepbound: A New Frontier in Weight Management In the ongoing battle against obesity and weight-related health issues, a new medication called Zepbound has emerged as a promising treatment option
While this type of cancer was only found in rodent studies (not in humans), people who have a personal or family history of thyroid cancer, including medullary thyroid carcinoma (MTC), or MEN2 syndrome shouldn't take GLP-1 medications like Mounjaro or Ozempic
Following the completion of these trials, the developer is expected to submit a New Drug Application (NDA) to the FDA in early 2027
Amgens Repatha has shown powerful protection against heart disease even before the first cardiac event
For patients managing type 2 diabetes and considering weight loss strategies, we offer personalized consultations to explore the potential off-label use of Tirzepatide
Among its predecessors, Liraglutide (Victoza, Saxenda), Exenatide (Byetta), Semaglutide (Ozempic, Rybelsus, Wegovy), Lixisenatide (Adlyxin), Dulaglutide ( Trulicity) are GLP-1 receptor agonists,Tirzepatide (Mounjaro) is a GLP-1/GIP dual receptor co-agonist
